Ciloa
Ciloa is a pioneer in the bioengineering of extracellular vesicles to develop new generations of therapeutics and preventive solutions to improve patients' lives.
Montpellier, Francewww.ciloa.bio ↗
Total raised
€6.5M
€6,500,000
Funding rounds
1
Investors
3
distinct backers
Active since
2025-07
latest 2025-07
Funding by year
EUR raised per yearSignals
High confidenceRaise-next likelihood33
base rate 30% for Other
- ▲ In typical raise window
- ▼ Low backer re-investment
Timing: in window vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2025-07-09 | Other | €6.5M | Bpifrance,France 2030 ‘Biotherapies and Biomanufacturing of Innovative Therapies’ ,French Government | View deal → |
Investors
3Related news
Similar companies
same sector or country- Automotive Cells Company (ACC)€4.4BFrance · Transportation
- Mistral AI€3.5BFrance · AI
- Philips€2.6BNetherlands · Healthtech
- Verkor€2.4BFrance · Energy
- Isomorphic Labs€2.3BUK · Healthtech
- ContentSquare€1.3BFrance · Software